Trial Review

Reset your password and enable multi-factor authentication (MFA)


For ANZCTR account holders: to help ensure the cyber safety of your account, you’ll need to reset your password and set-up multi-factor authentication (MFA) as per the instructions below.


  1. Go to the Login page, click ‘reset password’ and follow the instructions.
  2. Check your email for the link to set a new password.
  3. Create a new password that meets requirements. New passwords must include at least one lowercase letter, one uppercase letter, one number and one special character (e.g. !#$%&@).
  4. Return to the Login page and enter your new password. A verification code will be sent to your email.
  5. Check your email for the code and enter it on the Login page. If the code is entered incorrectly, you can re-enter the correct one or request a new one.

Learn more about MFA and its importance on the Australian Signals Directorate website.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619000334101
Ethics application status
Approved
Date submitted
25/01/2019
Date registered
4/03/2019
Date last updated
Type of registration
Prospectively registered

Titles & IDs
Public title
Parent and Child Group Cognitive Behavioural Therapy for Anxiety Disorders
Scientific title
Concurrent Parent-Child Transdiagnostic Cognitive-Behavioural Therapy for Anxiety Disorders
Secondary ID [1] 297193 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Anxiety Disorders 311244 0
Condition category
Condition code
Mental Health 309864 309864 0 0
Anxiety

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
A 10-week face-to-face cognitive behaviour therapy intervention will be provided to participants (parent child dyad). Ten separate but concurrent parent and child group treatment sessions will be provided in a group format of approximately 5-10 participants per group. One, 2 hour group treatment session will occur each week, over 10 weeks. Treatment sessions will include relevant psychological education and the development of skills to best treat emotional symptoms. Treatment related homework tasks are expected to be completed in-between group treatment sessions. Homework tasks are designed specifically based on the participants needs. The intervention will be delivered in a university based psychology clinic by doctoral-level students (provisional psychologists), with oversight from a registered clinical psychologist with extensive experience in clinical practice and research.
Intervention code [1] 313450 0
Treatment: Other
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 318812 0
Adult/Parent Participants: Examining the change in indices of anxiety severity from baseline and post-treatment. For adult parent participants, anxiety severity scores will be obtained from the Clinician Severity Rating in the Anxiety Diagnostic Interview Schedule Version 5 (ADIS-5).
Timepoint [1] 318812 0
Baseline, and within 4 weeks post-treatment.
Primary outcome [2] 318813 0
Child Participants: Examining the change in indices of anxiety severity from baseline and post-treatment. For child participants, anxiety severity scores will be obtained from the Clinician Severity Rating in the Anxiety Diagnostic Interview Schedule Parent/Child Version 4 (ADIS-4 P/C).
Timepoint [2] 318813 0
Baseline, and within 4 weeks post-treatment.
Secondary outcome [1] 366131 0
Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Egna Minnen Betraffande Uppfostran – Short Form Parent.
Timepoint [1] 366131 0
Baseline and Week 10 of treatment.
Secondary outcome [2] 366718 0
Adult/Parent participants: Measure changes in parenting knowledge throughout treatment using pre- and post-treatment scores on the Knowledge of Effective Parenting Scale.
Timepoint [2] 366718 0
Baseline and Week 10 of treatment.
Secondary outcome [3] 366782 0
Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Parenting and Family Adjustment Scale.
Timepoint [3] 366782 0
Baseline and Week 10 of treatment.
Secondary outcome [4] 366783 0
Adult/Parent participants: Measure changes in parenting behaviours throughout treatment using pre- and post-treatment scores on the Parenting Scale.
Timepoint [4] 366783 0
Baseline and Week 10 of treatment.
Secondary outcome [5] 366784 0
Adult/Parent participants: Measure changes in parenting knowledge throughout treatment using pre- and post-treatment scores on the Parenting Sense of Competency Scale.
Timepoint [5] 366784 0
Baseline and Week 10 of treatment.

Eligibility
Key inclusion criteria
Adult/Parent Participants:
Adult 18+ years of age, with a DSM-V primary diagnosis of an anxiety and/or anxiety related disorder, who has one child with a DSM-V primary diagnosis of an anxiety and/or anxiety related disorder.

Child Participants:
Children aged 8-12 years with a DSM-V primary diagnosis of an anxiety and/or anxiety related disorder, who has one parent with a DSM-V primary diagnosis of an anxiety and/or anxiety related disorder.
Minimum age
8 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Adult/Parent Participants:
-Primary DSM-V diagnosis other than an anxiety disorder and/or anxiety related disorder.
-Inability to read and communicate in English sufficiently to understand and participate in assessment and treatment with English-speaking therapists.
-Evidence of dementia or other neurocognitive condition that might interfere with informed consent, or understanding and participating in treatment.
-Evidence of serious suicidality, current alcohol or illicit substance dependence, or any other condition of sufficient severity that requires immediate clinical prioritisation.

Child Participants:
-Primary DSM-V diagnosis other than an anxiety disorder and/or anxiety related disorder.
-Inability to read and communicate in English sufficiently to understand and participate in assessment and treatment with English-speaking therapists.
-Evidence of a neurocognitive/neurodevelopmental condition that might interfere with understanding and participating in treatment.
-Evidence of serious suicidality or any other condition of sufficient severity that requires immediate clinical prioritisation.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
29/03/2019
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
60
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC

Funding & Sponsors
Funding source category [1] 301761 0
University
Name [1] 301761 0
Monash University
Country [1] 301761 0
Australia
Primary sponsor type
Individual
Name
Professor Peter Norton
Address
Monash Psychology Centre
Building 1, 270 Ferntree Gully Road
Notting Hill, VIC.
AUSTRALIA, 3168
Country
Australia
Secondary sponsor category [1] 301678 0
None
Name [1] 301678 0
Address [1] 301678 0
Country [1] 301678 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 302469 0
Monash University Human Research Ethics Committee
Ethics committee address [1] 302469 0
Ethics committee country [1] 302469 0
Australia
Date submitted for ethics approval [1] 302469 0
21/09/2018
Approval date [1] 302469 0
29/11/2018
Ethics approval number [1] 302469 0
9781

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 90326 0
Prof Peter Norton
Address 90326 0
Monash Psychology Centre Building 1, 270 Ferntree Gully Road Notting Hill, VIC. AUSTRALIA, 3168
Country 90326 0
Australia
Phone 90326 0
+61 3 9902 4480
Fax 90326 0
+61 3 9905 0605
Email 90326 0
[email protected]
Contact person for public queries
Name 90327 0
Peter Norton
Address 90327 0
Monash Psychology Centre Building 1, 270 Ferntree Gully Road Notting Hill, VIC. AUSTRALIA, 3168
Country 90327 0
Australia
Phone 90327 0
+61 3 9902 4480
Fax 90327 0
+61 3 9905 0605
Email 90327 0
[email protected]
Contact person for scientific queries
Name 90328 0
Peter Norton
Address 90328 0
Monash Psychology Centre Building 1, 270 Ferntree Gully Road Notting Hill, VIC. AUSTRALIA, 3168
Country 90328 0
Australia
Phone 90328 0
+61 3 9902 4480
Fax 90328 0
+61 3 9905 0605
Email 90328 0
[email protected]

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided
Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.